BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Advanced Radiology Ltd Among the First in the U.S. to Offer New Alzheimer's Disease Tracer


8/9/2012 10:42:08 AM

BALTIMORE, Aug. 8, 2012 /PRNewswire/ -- Advanced Radiology, a division of RadNet, Inc., a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of 237 fully-owned and operated outpatient imaging centers, announced it will be one of a small number of imaging centers in the U.S. to offer Amyvid, a radioactive tracer used in positron emission tomography computed tomography (PET/CT) imaging that helps to detect the quantity of beta-amyloid plaque in patient's brains. The Food and Drug Administration (FDA) approved Amyvid in April 2012.

Research has shown every patient with AD has increased levels of beta-amyloid plaque deposits in the brain at autopsy; patients that do not have identifiable beta-amyloid plaques in their brain at autopsy did not suffer from an AD diagnosis. A positive Amyvid scan indicates measurable beta-amyloid plaque build-up is present in the patient's brain. Beta-amyloid deposits do not always lead to an AD diagnosis a positive Amyvid scan cannot diagnose a patient with AD.

"Amyvid is the first test that can effectively rule out Alzheimer's disease (AD) in patients who are being evaluated for cognitive impairment," Ethan Spiegler, M.D., chief of nuclear medicine at Advanced Radiology and board certified radiologist. "The ability to persuasively rule out AD can help physicians treat other causes of cognitive impairment and help families better plan for the future of their loved ones."

More than 20 percent of AD cases are currently misdiagnosed. According to the Alzheimer's Association, AD is the sixth leading cause of death in the US. They estimate 100,000 Marylanders will have AD by 2025.

About Advanced Radiology

Advanced Radiology, the most preferred outpatient imaging provider in Maryland, provides advanced diagnostic imaging services in a caring environment in more than 20 outpatient centers and five hospitals in Anne Arundel, Baltimore, Carroll, Harford and Howard Counties. Its comprehensive services include high strength Open MRI, 3T and 1.5T MRI, CT, PET/CT, digital mammography, bone density, nuclear medicine, ultrasound, fluoroscopy and digital X-ray. The practice offers all-digital technology plus secure, online access to images and reports. For more information, visit AdvancedRadiology.com.

SOURCE Advanced Radiology


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->